Skip to content

Fortrea Holdings Inc. FTRE Preferred Stock, Shares Outstanding

Preferred Stock, Shares Outstanding at other companies

Charles River Laboratories logo
Charles River LaboratoriesCRL
IQVIA logo
IQVIAIQV
Medpace Holdings, Inc. logo
Medpace Holdings, Inc.MEDP
Labcorp Holdings logo
Labcorp HoldingsLH
Mirum Pharmaceuticals, Inc. logo
Mirum Pharmaceuticals, Inc.MIRM
Neurocrine Biosciences logo
Neurocrine BiosciencesNBIX

Other financials

Income statement

See full
Revenue$636.5M-2.3%
Gross profit$123.6M+6.1%
Operating income-$3.4M+99.3%
Net income-$23.6M+95.8%
EPS (diluted)-$0.25+96.0%

Balance sheet

See full
Cash & equivalents$147.5M+45.2%
Total debt$1.1B-13.1%
Total equity$525.9M-38.8%
Total assets$2.7B-14.0%

Cash flow

See full
Operating cash flow-$17.0M+86.3%
CapEx$8.0M+176%
Free cash flow-$25.0M+80.3%

Valuation

See full
Market cap$1.61B+29.3%
Enterprise value$2.58B-0.8%
P/S0.6×+0.1×

Profitability

See full
Gross margin18.9%-1.3pp
Operating margin-13.1%-4.1pp
Net margin-16.5%-5.0pp
FCF margin5.8%+1.7pp

Returns & leverage

See full
Return on equity-64.5%0.0pp
Debt / equity2.1×+0.6×
Current ratio0.9×0.0×

Where this comes from

Reported directly by Fortrea Holdings Inc. in its filing.

Tagged under the XBRL concept us-gaap:PreferredStockSharesOutstanding.

The official record: Fortrea Holdings Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Fortrea Holdings Inc.'s preferred stock, shares outstanding.

Connect your AI assistant and see it in context, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Fortrea Holdings Inc.'s preferred stock, shares outstanding?
Fortrea Holdings Inc. (FTRE) reported preferred stock, shares outstanding of $0 in Q1 2026.